Internal Medicine, Hematology & Oncology · Bethlehem, PA
NPI
1003927559
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
306 S New St Ste 201
Bethlehem, PA, 18015
Phone (610) 866-0113
Groups this clinician bills Medicare through
Medicare paid, 2024
$285K
40,751 services
Medicare patients, 2024
101
Average age 74
Drug cost, 2024
$2.1M
786 prescriptions
Company payments, 2025
$1,011
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna A Niewiarowska was code 85025 (blood count), 550 times for 89 patients. In total Anna A Niewiarowska billed 40,751 services in 113 codes, and Medicare paid $285K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 550 | 89 | $7.56 | $4,159 |
| 80053 Clinical Chemistry | Office | 520 | 85 | $10.28 | $5,346 |
| 83615 Clinical Chemistry | Office | 488 | 86 | $5.89 | $2,873 |
| 83735 Clinical Chemistry | Office | 485 | 86 | $6.53 | $3,169 |
| 36415 Venipuncture Blood Collection | Office | 458 | 78 | $8.60 | $3,937 |
| 96372 Injection Administration | Office | 276 | 27 | $10.38 | $2,866 |
| 96367 Intravenous Infusion, Hydration | Office | 233 | 17 | $20.88 | $4,866 |
| 96375 Injection Administration | Office | 202 | 15 | $11.27 | $2,277 |
| 99215 Office E&M - Established | Office | 197 | 71 | $121.94 | $24K |
| 84100 Clinical Chemistry | Office | 151 | 23 | $4.65 | $702 |
| J3490 Unclassified drugs | Office | 113 | 19 | $0.55 | $61.75 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 103 | 15 | $0.64 | $65.52 |
| 96413 Chemotherapy Administration | Office | 92 | 16 | $92.55 | $8,515 |
| 82378 Clinical Chemistry | Office | 91 | 31 | $18.21 | $1,657 |
| 84550 Clinical Chemistry | Office | 74 | 13 | $4.43 | $328 |
By year: 2022 $1.1M for 77,596 services; 2023 $564K for 56,119 services; 2024 $285K for 40,751 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 550 | 89 | $7.56 | $4,159 |
| 80053 Clinical Chemistry | 520 | 85 | $10.28 | $5,346 |
| 83615 Clinical Chemistry | 488 | 86 | $5.89 | $2,873 |
| 83735 Clinical Chemistry | 485 | 86 | $6.53 | $3,169 |
| 36415 Venipuncture Blood Collection | 458 | 78 | $8.60 | $3,937 |
| 84100 Clinical Chemistry | 151 | 23 | $4.65 | $702 |
| 82378 Clinical Chemistry | 91 | 31 | $18.21 | $1,657 |
| 84550 Clinical Chemistry | 74 | 13 | $4.43 | $328 |
| 86300 Immunoassay | 74 | 20 | $19.89 | $1,472 |
| 82306 Clinical Chemistry | 69 | 55 | $29.01 | $2,002 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna A Niewiarowska prescribed most often to Medicare patients was Fondaparinux Sodium, with 49 prescriptions and refills. In total Anna A Niewiarowska wrote 786 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fondaparinux Sodium Generic | 49 | 49 | 13 | $39K |
| Zarxio Filgrastim-Sndz | 33 | 33 | Under 11 | $42K |
| Procrit Epoetin Alfa | 27 | 27 | Under 11 | $96K |
| Fulvestrant Generic | 26 | 26 | Under 11 | $5,528 |
| Gabapentin Generic | 24 | 36 | 11 | $222 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 41 | Under 11 | $181 |
| Metoprolol Succinate Generic | 21 | 56 | Under 11 | $344 |
| Neulasta Onpro Pegfilgrastim | 19 | 19 | Under 11 | $120K |
| Anastrozole Generic | 19 | 43 | Under 11 | $170 |
| Ciprofloxacin Hcl Generic | 19 | 19 | 14 | $263 |
| Xgeva Denosumab | 16 | 22 | Under 11 | $50K |
| Duloxetine Hcl Generic | 15 | 35 | Under 11 | $179 |
| Famotidine Generic | 15 | 17 | Under 11 | $76.05 |
| Eliquis Apixaban | 14 | 28 | Under 11 | $15K |
| Pantoprazole Sodium Generic | 14 | 32 | Under 11 | $178 |
Brand drugs: 313 claims; generic drugs: 473 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna A Niewiarowska $1,011 ($1,011 in general payments such as food, travel and fees) from 22 companies. The largest payer was Daiichi Sankyo Inc. with $254.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 7 | $254 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $77.71 |
| Novocure Inc. NVCR | 2 | $49.56 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $46 |
| Abbvie Inc. ABBV | 2 | $45.17 |
| Janssen Biotech, Inc. JNJ | 2 | $45.16 |
| Gilead Sciences, Inc. GILD | 2 | $42.06 |
| Incyte Corporation INCY | 2 | $40.69 |
| Iovance Biotherapeutics, Inc. IOVA | 1 | $31.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.